One of the interferons, it is a protein that was approved by America’s Food & Drug Administration (FDA) in 1993 to be used to treat multiple sclerosis (MS) disease.
Encounter a particular type of interferon, a naturally occurring protein produced by the cells of the body. This specific type of interferon is occasionally employed in the treatment of multiple sclerosis, a chronic autoimmune disease affecting the central nervous system. By leveraging the therapeutic properties of interferon, this treatment approach aims to modulate the immune response and reduce the frequency and severity of relapses in individuals with multiple sclerosis. The utilization of interferon exemplifies the continuous advancements in medical science, offering hope and improved outcomes for those living with this complex neurological condition.